Novartis AG (SWX:NOVNEE)

Novartis AG Statistics

Total Valuation

Novartis AG has a market cap or net worth of CHF 200.48 billion. The enterprise value is 218.64 billion.

Market Cap	200.48B
Enterprise Value	218.64B

Important Dates

The next estimated earnings date is Wednesday, February 4, 2026.

Earnings Date	Feb 4, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-3.84%
Shares Change (QoQ)	-1.02%
Owned by Insiders (%)	0.11%
Owned by Institutions (%)	37.92%
Float	1.83B

Valuation Ratios

The trailing PE ratio is 17.47 and the forward PE ratio is 15.01.

PE Ratio	17.47
Forward PE	15.01
PS Ratio	4.46
PB Ratio	5.62
P/TBV Ratio	n/a
P/FCF Ratio	12.84
P/OCF Ratio	11.93
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.89, with an EV/FCF ratio of 14.01.

EV / Earnings	19.05
EV / Sales	4.86
EV / EBITDA	10.89
EV / EBIT	13.41
EV / FCF	14.01

Financial Position

The company has a current ratio of 0.88, with a Debt / Equity ratio of 0.72.

Current Ratio	0.88
Quick Ratio	0.58
Debt / Equity	0.72
Debt / EBITDA	1.27
Debt / FCF	1.64
Interest Coverage	18.35

Financial Efficiency

Return on equity (ROE) is 32.62% and return on invested capital (ROIC) is 16.78%.

Return on Equity (ROE)	32.62%
Return on Assets (ROA)	12.13%
Return on Invested Capital (ROIC)	16.78%
Return on Capital Employed (ROCE)	27.17%
Revenue Per Employee	592,358
Profits Per Employee	151,242
Employee Count	75,883
Asset Turnover	0.53
Inventory Turnover	2.17

Taxes

In the past 12 months, Novartis AG has paid 1.62 billion in taxes.

Income Tax	1.62B
Effective Tax Rate	12.40%

Stock Price Statistics

The stock price has increased by +13.07% in the last 52 weeks. The beta is 0.49, so Novartis AG's price volatility has been lower than the market average.

Beta (5Y)	0.49
52-Week Price Change	+13.07%
50-Day Moving Average	102.77
200-Day Moving Average	97.72
Relative Strength Index (RSI)	54.80
Average Volume (20 Days)	180,000

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novartis AG had revenue of CHF 44.95 billion and earned 11.48 billion in profits. Earnings per share was 5.82.

Revenue	44.95B
Gross Profit	34.27B
Operating Income	16.31B
Pretax Income	13.09B
Net Income	11.48B
EBITDA	19.87B
EBIT	16.31B
Earnings Per Share (EPS)	5.82

Balance Sheet

The company has 7.71 billion in cash and 25.53 billion in debt, giving a net cash position of -17.82 billion.

Cash & Cash Equivalents	7.71B
Total Debt	25.53B
Net Cash	-17.82B
Net Cash Per Share	n/a
Equity (Book Value)	35.68B
Book Value Per Share	18.42
Working Capital	-3.03B

Cash Flow

In the last 12 months, operating cash flow was 16.80 billion and capital expenditures -1.19 billion, giving a free cash flow of 15.61 billion.

Operating Cash Flow	16.80B
Capital Expenditures	-1.19B
Free Cash Flow	15.61B
FCF Per Share	n/a

Margins

Gross margin is 76.25%, with operating and profit margins of 36.29% and 25.53%.

Gross Margin	76.25%
Operating Margin	36.29%
Pretax Margin	29.13%
Profit Margin	25.53%
EBITDA Margin	44.21%
EBIT Margin	36.29%
FCF Margin	34.73%

Dividends & Yields

Novartis AG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	54.32%
Buyback Yield	3.84%
Shareholder Yield	3.84%
Earnings Yield	5.72%
FCF Yield	7.79%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Novartis AG has an Altman Z-Score of 3.8 and a Piotroski F-Score of 7.

Altman Z-Score	3.8
Piotroski F-Score	7